(1)
Stojsic, V.; Zaric, B.; Simurdic, P.; Kovacevic, T.; Bokan, D.; Djekic Malbasa, J.; Sarcev, T.; Stojanovic, G.; Bursac, D.; Nikolin, B. Real World Data Survival Outcomes of First Line Immunotherapy With Pembrolizumab in High Expressers With Stage IV Non-Small Cell Lung Cancer. Radiol Oncol 2026, 60, 450-458.